Common early experiences include: Reduced appetite : Many people notice decreased hunger and earlier satiety during meals within days of the first injection or dose Mild gastrointestinal symptoms : Nausea (affecting 2040% of patients), occasional vomiting, or changes in bowel habits are usually mild and transient Injection site reactions : Minor redness, itching, or discomfort at injection sites is common but typically resolves quickly Fatigue : Some individuals report feeling more tired initially as their body adjusts to reduced calorie intake By weeks 24 , appetite suppression typically becomes more pronounced, and patients often find it easier to adhere to portion control and dietary modifications
By helping your body use insulin more effectively, you can prevent excess fat storage, helping you lose weight more efficiently
Injection sites: Inject in the upper arm, abdomen (about 2 inches away from the belly button), or top of the thigh
Encourage more generic drug approvals, do it the right way, or inspect these compounders and make them actual legitimate legal entities, Ball said
In contrast, drugs modeled after gastrointestinal hormones, such as glucagon-like peptide-1 (GLP-1), have been shown to exhibit fewer side effects while demonstrating high efficacy in obesity treatment
.jpg)
